{"id":"hepa-i","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Injection site pain or swelling"},{"rate":"1-5","effect":"Fever"},{"rate":"1-5","effect":"Headache"},{"rate":"1-3","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains inactivated (killed) hepatitis A virus particles that trigger both humoral and cellular immune responses, leading to the production of protective antibodies (anti-HAV IgG) and memory B cells. This provides long-term immunity against hepatitis A infection without causing disease.","oneSentence":"HepA-I is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:47:32.750Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of hepatitis A infection in children and adults"}]},"trialDetails":[{"nctId":"NCT06442449","phase":"PHASE4","title":"Booster Dose of sIPV Co-administered With MMR and HepA-I.","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2024-08-08","conditions":"Poliomyelitis","enrollment":889},{"nctId":"NCT06460545","phase":"PHASE4","title":"Phase IV Study of Concomitant Administration of the sIPV and HepA","status":"NOT_YET_RECRUITING","sponsor":"Institute of Medical Biology, Chinese Academy of Medical Sciences","startDate":"2024-06-15","conditions":"Polio, Hepatitis A","enrollment":2000}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"HepA-I","genericName":"HepA-I","companyName":"Sinovac Biotech Co., Ltd","companyId":"sinovac-biotech-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"HepA-I is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus. Used for Prevention of hepatitis A infection in children and adults.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}